Drug therapy for the patient with resistant hypertension. (March 2015)

• Record Type: Journal Article
• Authors: Donazzan, Luca; Ewen, Sebastian; Papademetriou, Vasilios; Linicus, Yvonne; Linz, Dominik; Böhm, Michael; Mahfoud, Felix
• Is Part Of: Future cardiology. Volume 11:Number 2(2015)
• Page Start: 191
• Page End: 202
• Publication Date: 2015-03
• Subjects: baroceptor stimulation -- drug adherence -- medical therapy -- renal denervation -- resistant hypertension; Cardiology -- Research -- Periodicals; 616.12005
• DOI: 10.2217/fca.15.9
• Languages: English
• ISSNs: 1479-6678

Abstract

ABSTRACT : Resistant hypertension is associated with high morbidity and mortality. Resistant hypertension is defined as blood pressure above targets despite treatment with at least three antihypertensive drugs in adequate dose and combination. Nonadherence is a frequent cause of uncontrolled hypertension and can be improved by providing fixed dose (of two or three agents) single pill combination. Triple combination of the most widely used antihypertensive agents (renin–angiotensin–aldosterone system antagonists, calcium channel blockers and diuretics) is a safe and effective therapy. Fourth line therapy is the use of an aldosterone antagonist. Renal denervation and baroreceptor stimulation can be considered in patients who remained uncontrolled despite optimal medical therapy.